Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010

BACKGROUND: Long-term persistence to treatment for chronic disease is difficult for patients to achieve, regardless of the disease or medication being used. The objective of this investigation was to examine treatment persistence with glatiramer acetate (GA) relative to available disease-modifying t...

Descripción completa

Detalles Bibliográficos
Autores principales: Oleen-Burkey, MerriKay, Cyhaniuk, Anissa, Swallow, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897905/
https://www.ncbi.nlm.nih.gov/pubmed/24423119
http://dx.doi.org/10.1186/1471-2377-14-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897905/
https://www.ncbi.nlm.nih.gov/pubmed/24423119
http://dx.doi.org/10.1186/1471-2377-14-11

Ejemplares similares